Palisade Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Palisade Bio and other ETFs, options, and stocks.About PALI
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery.
CEOJ. D. Finley
CEOJ. D. Finley
Employees8
Employees8
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2011
Founded2011
Employees8
Employees8
PALI Key Statistics
Market cap223.45M
Market cap223.45M
Price-Earnings ratio-0.27
Price-Earnings ratio-0.27
Dividend yield—
Dividend yield—
Average volume5.07M
Average volume5.07M
High today$1.69
High today$1.69
Low today$1.69
Low today$1.69
Open price$1.62
Open price$1.62
Volume3.72K
Volume3.72K
52 Week high$3.30
52 Week high$3.30
52 Week low$0.53
52 Week low$0.53
Stock Snapshot
Palisade Bio(PALI) stock is priced at $1.69, giving the company a market capitalization of 223.45M. It carries a P/E multiple of -0.27.
On 2025-11-10, Palisade Bio(PALI) stock moved within a range of $1.69 to $1.69. With shares now at $1.69, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading volume for Palisade Bio(PALI) stock has reached 3.72K, versus its average volume of 5.07M.
The stock's 52-week range extends from a low of $0.53 to a high of $3.30.
The stock's 52-week range extends from a low of $0.53 to a high of $3.30.
People also own
Based on the portfolios of people who own PALI. This list is generated using Robinhood data, and it’s not a recommendation.